Yes, chromatography can absolutely be used to purify biological samples. It is one of the most widely applied separation techniques in life sciences and biochemistry, capable of isolating proteins, antibodies, nucleic acids, and other biomolecules with high selectivity and purity. The right chromatography technique depends on the properties of the target molecule and the complexity of the sample matrix. This article unpacks the most important questions researchers face when applying chromatography to biological samples.
What types of chromatography work best for biological samples?
The most effective chromatography techniques for biological samples are affinity chromatography, ion exchange chromatography, size exclusion chromatography, and hydrophobic interaction chromatography. Each method exploits a different physical or chemical property of the target biomolecule, and the best choice depends on the molecule’s structure, charge, size, and binding behavior.
Biological samples are structurally diverse and often fragile, so the chosen technique must deliver high resolution without denaturing or degrading the target. In practice, a multi-step purification strategy is common, combining two or three techniques in sequence to achieve the required purity level.
- Affinity chromatography exploits specific binding interactions and is ideal for proteins, antibodies, and enzymes
- Ion exchange chromatography separates molecules based on charge and is widely used for nucleic acids and charged proteins
- Size exclusion chromatography (SEC) separates by molecular weight and is particularly useful as a polishing step
- Hydrophobic interaction chromatography (HIC) separates based on surface hydrophobicity and works well after ammonium sulfate precipitation
- Reversed-phase chromatography is used for smaller peptides and analytical applications but can denature larger proteins
How does affinity chromatography purify proteins and antibodies?
Affinity chromatography purifies proteins and antibodies by exploiting highly specific, reversible binding interactions between the target molecule and a ligand immobilized on a stationary phase. The target binds selectively while contaminants pass through, and the purified molecule is then released using an elution buffer that disrupts the binding interaction.
This selectivity makes affinity chromatography one of the most powerful single-step purification methods available for biologics. For monoclonal antibodies, Protein A or Protein G resins are the industry standard, binding the Fc region of IgG antibodies with remarkable specificity. For recombinant proteins, His-tag or GST-tag systems are commonly used, where the protein is engineered to carry a short affinity tag that binds a complementary resin.
The technique can achieve purification factors of several hundred-fold in a single pass, dramatically reducing the number of downstream steps required. Because the binding is driven by molecular recognition rather than bulk physical properties, affinity chromatography can isolate the target even from a crude cell lysate or fermentation broth, making it an early-stage capture step in most biologic purification workflows.
What challenges arise when purifying biological samples with chromatography?
Purifying biological samples with chromatography presents several challenges that are largely absent in small-molecule work. Biomolecules are structurally sensitive, often unstable under harsh conditions, and exist in complex matrices that can foul columns or interfere with separation. Managing these factors requires careful method development and appropriate equipment choices.
Key challenges include:
- Sample stability: Proteins and nucleic acids can degrade rapidly if exposed to elevated temperatures, extreme pH, or proteases present in the sample matrix
- Column fouling: Lipids, cell debris, and aggregated proteins can clog or contaminate the stationary phase, reducing column lifetime and reproducibility
- Co-elution of contaminants: Host cell proteins, endotoxins, and nucleic acids may share similar properties with the target and require additional polishing steps to remove
- Resin compatibility: Not all stationary phases tolerate the mild conditions required to preserve biological activity, so resin selection must balance separation performance with biocompatibility
- Scale-up complexity: Methods that work at analytical scale do not always translate directly to preparative or process scale without re-optimization
Working in a temperature-controlled environment, pre-treating samples to remove particulates, and validating cleaning procedures are standard practices for managing these challenges in research and development laboratories across the Benelux.
How does chromatography for biologics differ from small-molecule purification?
Chromatography for biologics differs fundamentally from small-molecule purification in terms of operating conditions, stationary phase chemistry, detection methods, and the sensitivity of the target to process conditions. Biologics require gentler methods, aqueous mobile phases, and resins specifically designed to preserve three-dimensional molecular structure and biological activity.
Small-molecule purification, such as flash chromatography or preparative HPLC for synthetic compounds, typically uses organic solvents, high pressures, and silica-based stationary phases. These conditions would denature or destroy most proteins and nucleic acids. Biologic purification instead operates at low pressures, near-physiological pH, and with aqueous buffers formulated to maintain molecular stability.
Detection also differs. Small molecules are routinely monitored at UV wavelengths suited to aromatic or conjugated systems. Proteins are typically detected at 280 nm due to tryptophan and tyrosine absorbance, while nucleic acids are monitored at 260 nm. Activity assays or immunoassays are often needed alongside UV detection to confirm that the purified fraction retains its biological function.
Finally, regulatory expectations for biologics purification in pharmaceutical and biopharmaceutical research are typically more stringent, with documentation requirements around GMP and GLP principles playing a larger role in how workflows are designed and validated.
When should size exclusion chromatography be used for biological samples?
Size exclusion chromatography should be used for biological samples when the goal is to separate molecules by molecular weight, remove aggregates, exchange buffers, or assess the homogeneity of a purified protein or nucleic acid preparation. It is most commonly applied as a final polishing step after earlier capture and intermediate purification stages.
SEC works by passing the sample through a porous matrix. Smaller molecules enter the pores and are retained longer, while larger molecules are excluded and elute first. Because separation is based purely on hydrodynamic size, SEC does not require binding or elution steps, making it a gentle and predictable technique that preserves biological activity.
In the context of protein purification chromatography, SEC is particularly valuable for removing high-molecular-weight aggregates that may have formed during upstream processing. Aggregation is a common problem in biologic production and can affect both potency and safety in research applications. SEC can also be used analytically to characterize molecular weight distribution, oligomeric state, and sample homogeneity, providing quality information alongside purification.
What equipment is needed to run chromatography on biological samples?
Running chromatography on biological samples requires a liquid chromatography system capable of operating at low to moderate pressures with precise flow control, along with biocompatible columns packed with appropriate resins, a UV detector, and a fraction collector. Temperature control is often necessary to maintain sample stability throughout the run.
Unlike high-pressure systems used for small-molecule HPLC, systems designed for biologics typically operate at lower pressures to protect the stationary phase and the sample. Peristaltic pumps or low-pressure gradient systems are common in academic and research settings, while preparative-scale work in industrial labs may use more sophisticated systems with automated buffer blending, conductivity monitoring, and inline pH measurement.
Column selection is critical. The resin must match the chosen separation mechanism, whether affinity, ion exchange, or size exclusion, and the column dimensions must be appropriate for the sample volume and target load. Columns should be sanitizable and compatible with the cleaning agents used to remove biological contaminants between runs.
Supporting equipment includes cold rooms or refrigerated cabinets for temperature-sensitive samples, centrifuges and filtration units for sample pre-treatment, and analytical tools such as SDS-PAGE or activity assays for fraction analysis. For laboratories operating under GLP- or GMP-aligned frameworks, system qualification and documentation are also part of the equipment setup.
How ChemSPX supports chromatography for biological samples
Laboratories in the Benelux region working with biological samples can rely on ChemSPX for expert guidance on selecting and implementing the right chromatography setup. ChemSPX’s team of Sales Engineers and Product Specialists works closely with researchers to match instrumentation to the specific demands of protein purification, antibody isolation, and other biologic separation workflows.
- Application-level advice on technique selection, column chemistry, and method development for biological samples
- Supply and installation of preparative and flash chromatography systems suited to biologics workflows
- IQ/OQ qualification and calibration services to support GLP- and GMP-aligned laboratory environments
- Ongoing service and support to maintain instrument performance and compliance over time
Whether you are setting up a new purification workflow or optimizing an existing one, ChemSPX’s specialists are ready to help. Contact ChemSPX to discuss your chromatography needs with an expert.
Foire aux questions
How do I decide which chromatography technique to use first in a multi-step purification workflow?
The first step in a multi-step workflow is typically a high-capacity capture step designed to reduce sample volume and remove the bulk of contaminants quickly. Affinity chromatography is the most common choice here because it delivers a high purification factor in a single pass, even from crude starting materials like cell lysates or fermentation broths. If no affinity tag or natural ligand is available, ion exchange chromatography is a practical alternative as the capture step, followed by a secondary technique such as hydrophobic interaction chromatography or size exclusion as a polishing step.
What is the best way to prevent protein degradation during a chromatography run?
The most effective precautions are working at low temperatures (typically 4°C), using buffers supplemented with protease inhibitors, and minimizing the total processing time between sample preparation and column loading. Pre-clearing the sample by centrifugation or filtration before loading also reduces the risk of column fouling and limits exposure to proteases present in cell debris. For particularly sensitive proteins, all buffers and equipment should be pre-chilled and the entire run conducted in a cold room or with a refrigerated chromatography system.
Can the same chromatography column be reused across multiple purification runs, and how should it be cleaned?
Yes, most chromatography columns used for biological samples can be regenerated and reused, but proper cleaning-in-place (CIP) procedures are essential to maintain performance and prevent cross-contamination. Common CIP protocols involve washing the column with sodium hydroxide solution (typically 0.1–0.5 M NaOH), which removes bound proteins, lipids, and endotoxins while also sanitizing the resin. The number of reuse cycles a column can reliably support depends on the resin type, the complexity of the sample matrix, and how rigorously cleaning procedures are applied and validated.
How do I know if my purified biological sample is pure enough, and what analytical methods should I use?
Purity assessment should combine multiple complementary methods rather than relying on a single technique. SDS-PAGE is the standard first check, giving a visual indication of protein banding pattern and the presence of contaminants, while densitometry can provide a rough purity estimate. For more rigorous characterization, HPLC-SEC can quantify aggregate levels, ELISA or activity assays confirm that the target retains biological function, and endotoxin testing (LAL assay) is necessary when the sample will be used in cell-based or in vivo experiments. The required purity level ultimately depends on the downstream application.
What are the most common mistakes researchers make when scaling up a chromatography method from bench to preparative scale?
One of the most frequent mistakes is assuming that simply increasing column volume and sample load will replicate bench-scale results without any re-optimization. At preparative scale, factors such as linear flow velocity, residence time, buffer consumption, and heat generated during the run all behave differently and must be re-evaluated. Another common error is neglecting to reassess sample pre-treatment steps, since particulates and aggregates that were manageable at small scale can cause serious column fouling at larger volumes. It is good practice to scale up incrementally, validating performance at each stage before moving to the next.
Is it possible to use chromatography to purify nucleic acids such as DNA or RNA, and are the methods different from protein purification?
Yes, chromatography is widely used for nucleic acid purification, particularly for applications requiring high-purity plasmid DNA, mRNA, or oligonucleotides. Ion exchange chromatography is the most common approach, exploiting the strong negative charge of the phosphate backbone to bind nucleic acids selectively to anion exchange resins. Reversed-phase and hydrophobic interaction chromatography are also used for oligonucleotide purification. The key differences from protein purification include the use of higher salt concentrations for elution, the absence of concern about maintaining tertiary structure, and the use of 260 nm rather than 280 nm as the primary UV detection wavelength.
What should I do if my target protein is not eluting from the affinity column as expected?
If the target protein fails to elute properly, the most likely causes are an elution buffer that is too mild to disrupt the binding interaction, incorrect pH, or insufficient imidazole concentration in the case of His-tag purification. Start by reviewing the elution conditions recommended for your specific resin and adjusting the pH, salt concentration, or competing ligand concentration incrementally. If the protein appears to be irreversibly bound or the resin has become fouled, stripping the column with a denaturing agent such as 6 M guanidine hydrochloride can help recover bound material for diagnostic purposes, even if the protein’s activity is lost.
Articles connexes
- How does drug formulation affect tablet manufacturing performance?
- Why can tablet dissolution change during manufacturing scale-up?
- How does in vitro permeation testing measure drug transport through skin?
- When should in vitro release testing be used in drug formulation?
- How does pH stability affect resin selection for protein purification?
Ce contenu a été généré à l'aide de l'IA et peut contenir des erreurs.